Rodman & Renshaw Starts Oncothyreon (ONTY) at Market Outperform, Sets Street-High Price Target at $10
Tweet
Share
E-mailGet Alerts ONTY Hot Sheet
Price: $1.21 --0%
Rating Summary:
7 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Shares of Oncothyreon (NASDAQ: ONTY) are rallying sharply Monday despite any news from the company. At last check, shares were up 9.8 percent to $4.61.
The stock seems to have pushed above a resistance level around $4.50 following a new Market Outperform rating from Rodman & Renshaw in an intraday research note. The firm set a Street-high price target on ONTY shares at $10.
The firm's new price target implies potential upside of about 117 percent from where the stock is trading Monday.
For more ratings news on Oncothyreon click here and for the rating history of Oncothyreon click here.
The stock seems to have pushed above a resistance level around $4.50 following a new Market Outperform rating from Rodman & Renshaw in an intraday research note. The firm set a Street-high price target on ONTY shares at $10.
The firm's new price target implies potential upside of about 117 percent from where the stock is trading Monday.
For more ratings news on Oncothyreon click here and for the rating history of Oncothyreon click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Canaccord Starts Galiano Gold (GAU:CN) at Buy
- JPMorgan Resumes SanDisk (SNDK) at Overweight
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
